SUTRO BIOPHARMA, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
SUTRO BIOPHARMA, INC. has filed 610 SEC EDGAR filings since 08 Nov 2006

SEC filing history

Showing 176-200 of 605 matching filings.

Per page
25
Current page
8
4

4 filing

Filing date
06 Mar 2024
Reporting date
04 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Mar 2024
Reporting date
04 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Mar 2024
Reporting date
01 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Mar 2024
Reporting date
01 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Mar 2024
Reporting date
01 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Mar 2024
Reporting date
01 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Mar 2024
Reporting date
01 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Mar 2024
Reporting date
29 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-277404

S-8

Filing date
27 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90656

SC 13G/A filing

Filing date
13 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90656

SC 13G/A

Filing date
12 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-275525

424B5

Filing date
09 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90656

SUTRO BIOPHARMA, INC.

Filing date
07 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
31 Jan 2024
Reporting date
29 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
31 Jan 2024
Reporting date
29 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
31 Jan 2024
Reporting date
29 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
31 Jan 2024
Reporting date
29 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38662

144 filing

Filing date
29 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90656

SC 13G/A filing

Filing date
24 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90656

SC 13G filing

Filing date
17 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Dec 2023
Reporting date
01 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-275525

EFFECT filing

Filing date
21 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .